Costo-Efectividad De Exploración De Miembros Pélvicos Para Prevenir Pie Diabético

  • Reyes-Chávez Prishila Danae Especialista en Medicina Familiar, Unidad de Medicina Familiar, Instituto Mexicano del Seguro Social, Delegación Querétaro, México
  • Villarreal-Ríos Enrique Especialista en Medicina Familiar, Unidad de Investigación Epidemiológica y en Servicios de Salud, Instituto Mexicano del Seguro Social, Delegación Querétaro, México
  • Martínez-Martínez Martha Leticia Especialista en Medicina Familiar, Docente Investigador Facultad de Medicina, Universidad Autónoma de Querétaro, México
  • Velázquez-Tlapanco Jorge Especialista en Medicina Familiar, Docente Investigador Facultad de Medicina, Universidad Autónoma de Querétaro, México
  • Camacho-Calderón Nicolás Especialista en Pediatría y Cardiopediatría. Docente Investigador Facultad de Medicina, Universidad Autónoma de Querétaro, México
  • Gallardo-Vidal Lilia Susana Especialista en Medicina Familiar, Unidad de Medicina Familiar, Instituto Mexicano del Seguro Social, Delegación Veracruz Sur, México
  • Bello-Sánchez Ma. Azucena Especialista en Medicina Familiar, Unidad de Medicina Familiar, Instituto Mexicano del Seguro Social, Delegación Veracruz Sur, México
  • Narváez-Escobedo Miguel Ángel Especialista en Medicina Familiar, Unidad de Medicina Familiar, Instituto Mexicano del Seguro Social, Delegación Veracruz Sur, México
  • Azpeitia-Castillo Nora Especialista en Medicina Integrada, Hospital General de Querétaro, Secretaría de Salud, Delegación Querétaro, México

Abstract

Diabetic neuropathy is a common and frequent complication of DM2. It is the main risk factor for ulcer and amputation of lower limbs. The risk of developing ulcer foot is 12 -25%. In the first level of care medical, history and physical examination of the patient with DM2 is performed to determine the appropriate treatment. Objective: Determine the costeffectiveness of the exploration of pelvic limbs to prevent diabetic foot. Materials and Methods: Cost-effectiveness design. Clinical records of patients with DM2. Sample calculation with the formula of percentages of two populations. Group 1, complete scan of pelvic limbs (n=15) and Group 2 with incomplete examination of lower limbs (n=40). Sociodemographic variables, health characteristics, type and number of laboratory studies requested, type and quantity of drugs prescribed were analyzed. The effectiveness was evaluated as absence of data from diabetic foot in five years follow- up. The cost of care was estimated with the profile of use and unit cost. Statistical analysis averages, percentages and cost-effectiveness. Results: The total cost in group 1 was $7,203.24 and $4,909.03 in 2. Group 1, the total cost in laboratory studies was $5,863.44, $ 187.62 in drugs and average cost of $ 1,152.18 in consultation; while in the 2, laboratory it was $ 3,596.76 , $ 186.24 medicines and average cost of consultation $ 1,126.03. The effectiveness for $ 5,000.00 in group 1 corresponds to $ 37.00 and in the group 2 to $79.75. Conclusions: It was no scanning showed that full pelvic limbs and timely detection of diabetic foot out cost-effective.

Downloads

Download data is not yet available.
Published
2016-08-30
How to Cite
Prishila Danae, R.-C., Enrique, V.-R., Martha Leticia, M.-M., Jorge, V.-T., Nicolás, C.-C., Lilia Susana, G.-V., Azucena, B.-S. M., Miguel Ángel, N.-E., & Nora, A.-C. (2016). Costo-Efectividad De Exploración De Miembros Pélvicos Para Prevenir Pie Diabético. European Scientific Journal, ESJ, 12(24), 137. https://doi.org/10.19044/esj.2016.v12n24p137